Keppra Tablets 250 mg/500 mg/750 mg/1 000 mg Tablets
PDF Leaflet Revision Date: 11 Oct 2013
Clinical Summary
Quick overview from the medicine insert
Indication
Monotherapy and adjunctive therapy for seizures.
Dosage (summary)
Starting dose 250 mg twice daily, max 1500 mg twice daily for adults.
Onset of Action / Duration
Onset: 1.3 hours, Duration: 7u00b11 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Probenecid
- Oral contraceptives
- Antiepileptic drugs
Contraindications
- Hypersensitivity to levetiracetam
- Pregnancy
- Lactation
Common side effects
- Somnolence
- Dizziness
- Asthenia
Counselling Points
- Report any mood changes
- Avoid driving if drowsy
- Take with or without food
Serious warnings
- Suicidal ideation
- Gradual discontinuation recommended
Important Disclaimer
The Keppra Tablets 250 mg/500 mg/750 mg/1 000 mg Tablets professional information leaflet below is the property of Glaxosmithkline South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
